Oscar Health (OSCR) Cash & Current Investments (2020 - 2026)

Oscar Health has reported Cash & Current Investments for 7 years, with the latest figure at $6.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 127.57% year-over-year to $6.8 billion; the trailing twelve-month figure through Mar 2026 stood at $6.8 billion (up 127.57% YoY), and the FY2025 full-year result was $4.0 billion, up 85.47% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $6.8 billion, up from $4.0 billion in the prior quarter.
• The five-year high for Cash & Current Investments was $6.8 billion in Q1 2026, with the low at $1.7 billion in Q3 2024.
• Historically, Cash & Current Investments has averaged $3.2 billion across 5 years, with a median of $3.0 billion in 2022.
• Annual changes were most pronounced in 2024 — Cash & Current Investments tumbled 30.04% — and 2026, when it soared 127.57%.
• Oscar Health's Cash & Current Investments stood at $3.0 billion in 2022, then retreated by 13.39% to $2.6 billion in 2023, then dropped by 15.96% to $2.2 billion in 2024, then soared by 85.47% to $4.0 billion in 2025, then jumped by 70.39% to $6.8 billion in 2026.
• The last three Cash & Current Investments figures came in at $6.8 billion (Q1 2026), $4.0 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.